FDA: Merck’s Gardasil stops gential warts in boys

Comments:  | Leave A Comment

WASHINGTON – Merck’s blockbuster vaccine Gardasil, which is already used to prevent cervical cancer in women, also stops viruses that cause genital warts in men, the Food and Drug Administration said recently.

WASHINGTON – Merck’s blockbuster vaccine Gardasil, which is already used to prevent cervical cancer in women, also stops viruses that cause genital warts in men, the Food and Drug Administration said recently.

In documents posted online, the FDA said the vaccine prevented genital warts in males 90 percent of the time.

The vaccine works by blocking the two strains of the human papilloma virus, or HPV, which causes irregular growths and rare types of cancer in male genitals.

Merck has asked the FDA to approve Gardasil for boys and men ages 9 to 26.

______

To read the rest of this article, subscribe to our digital or paper edition. For previous editions, contact us for details.

Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Tags:

Comments

blog comments powered by Disqus
Follow

Get every new post delivered to your Inbox.

Join 316 other followers